Allergy diagnostics is used to determine the nature and treatment course of allergic diseases. According to an editorial piece published in the World Allergy Journal in May 2014, about 300 million people suffered from asthma and about 200 to 250 million people suffered from food allergies in 2013. The prevalence of asthma has risen rapidly across the globe. According to the World Health Organization (WHO), about 300 million asthma cases were recorded globally in 2013 and are expected to increase to 400 million, by 2025. Furthermore, about 400 million people suffered from allergic rhinitis and about one-tenth of the population suffered from drug allergies in 2013. High incidence of allergic diseases is the most important growth driver for the allergy diagnostics market in the forecast period from 2014 to 2019.

Young children are highly susceptible to allergic diseases. According to estimates from the U.S. National Institute of Health (NIH), the incidence of food allergies in young children is close to twice than that in adults. In 2013, about 6% of young children in the U.S. suffered from food allergies, while the number for adults is estimated to be about 3%. The population of children aged 14 years and below increased from 1,817 million in 2003 to 1,851 million in 2012. This population segment accounted for about 26.42% of the global population in 2012. The large proportion of children aged below 14 years, who are at a higher risk for development for allergic disorders, will be an important driver for the allergy diagnostics market.

This report segments the global allergy diagnostics market by allergen, end user, product, and geography. The allergens segments included in this report are food allergens, inhaled allergens, and other allergens. Food allergens and inhaled allergens are each subsegmented into allergens of animal origin and plant origin. The end-user segments in this market are academic research institutes, diagnostics laboratories, hospitals, and other end users. The product segments included in this report are assay kits, consumables, and instruments. Immunoassay analyzers, luminometers, and other instruments are subsegments of the instruments product segment.

The geographic segments included in this report are Asia, Europe, North America and the Rest of the World (RoW). Asia is further divided into China, India, Japan, and the Rest of Asia. Europe is divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the Rest of Europe. North America includes Canada and the U.S. The RoW encompasses the Africa, Pacific and Oceania, and South America, Central America, & The caribbean.

A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global allergy diagnostics market and its subsegments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their allergy diagnostics market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised to see rapid growth. The report also includes company profiles of market leaders. These company profiles include the financial performances, product portfolios, and developments of each company. The report also provides a competitive landscape of the allergy diagnostics market. The competitive landscape covers the growth strategies adopted by industry players over the last three years. It also includes analyses of industry developments like mergers and acquisitions, agreements and partnerships, and new product launches.

More Info@ http://www.marketsandmarkets.com/Market-Reports/allergy-diagnostics-market-232871701.html